192 related articles for article (PubMed ID: 25447674)
1. Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.
Wang X; He H; Lu Y; Ren W; Teng KY; Chiang CL; Yang Z; Yu B; Hsu S; Jacob ST; Ghoshal K; Lee LJ
Biochim Biophys Acta; 2015 Jan; 1853(1):244-53. PubMed ID: 25447674
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
Xia H; Ooi LL; Hui KM
Hepatology; 2013 Aug; 58(2):629-41. PubMed ID: 23471579
[TBL] [Abstract][Full Text] [Related]
3. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
4. microRNA-19a-3p promotes tumor metastasis and chemoresistance through the PTEN/Akt pathway in hepatocellular carcinoma.
Jiang XM; Yu XN; Liu TT; Zhu HR; Shi X; Bilegsaikhan E; Guo HY; Song GQ; Weng SQ; Huang XX; Dong L; Janssen HLA; Shen XZ; Zhu JM
Biomed Pharmacother; 2018 Sep; 105():1147-1154. PubMed ID: 30021351
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Fang Y; Xue JL; Shen Q; Chen J; Tian L
Hepatology; 2012 Jun; 55(6):1852-62. PubMed ID: 22234835
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.
Kumarswamy R; Volkmann I; Jazbutyte V; Dangwal S; Park DH; Thum T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):361-9. PubMed ID: 22095988
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-760 Inhibits Doxorubicin Resistance in Hepatocellular Carcinoma through Regulating Notch1/Hes1-PTEN/Akt Signaling Pathway.
Tian T; Fu X; Lu J; Ruan Z; Nan K; Yao Y; Yang Y
J Biochem Mol Toxicol; 2018 Aug; 32(8):e22167. PubMed ID: 29968951
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma.
Tu K; Liu Z; Yao B; Han S; Yang W
Int J Oncol; 2016 Mar; 48(3):965-74. PubMed ID: 26708293
[TBL] [Abstract][Full Text] [Related]
10. Hsa_circ_0007059 sponges miR-421 to repress cell growth and stemness in hepatocellular carcinoma by the PTEN-AKT/mTOR pathway.
Hui Y; Jin D; Leng J; Liu D; Yuan P; Tang C; Wang Q
Pathol Res Pract; 2022 Jan; 229():153692. PubMed ID: 34847369
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A.
Ohta K; Hoshino H; Wang J; Ono S; Iida Y; Hata K; Huang SK; Colquhoun S; Hoon DS
Oncotarget; 2015 Feb; 6(5):3211-24. PubMed ID: 25633810
[TBL] [Abstract][Full Text] [Related]
12. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-331-3p promotes proliferation and metastasis of hepatocellular carcinoma by targeting PH domain and leucine-rich repeat protein phosphatase.
Chang RM; Yang H; Fang F; Xu JF; Yang LY
Hepatology; 2014 Oct; 60(4):1251-63. PubMed ID: 24825302
[TBL] [Abstract][Full Text] [Related]
14. Indole-3-carbinol inhibits cell proliferation and induces apoptosis in Hep-2 laryngeal cancer cells.
Wang YQ; Chen C; Chen Z; Xu Y; Wang Y; Xiao BK; Chen SM; Tao ZZ
Oncol Rep; 2013 Jul; 30(1):227-33. PubMed ID: 23604413
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of akt and NF-kappaB play important roles during indole-3-carbinol-induced apoptosis in breast cancer cells.
Rahman KM; Li Y; Sarkar FH
Nutr Cancer; 2004; 48(1):84-94. PubMed ID: 15203382
[TBL] [Abstract][Full Text] [Related]
16. miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway.
Qadir XV; Han C; Lu D; Zhang J; Wu T
Am J Pathol; 2014 Aug; 184(8):2355-64. PubMed ID: 24911372
[TBL] [Abstract][Full Text] [Related]
17. Loss of phosphatase and tensin homolog enhances cell invasion and migration through AKT/Sp-1 transcription factor/matrix metalloproteinase 2 activation in hepatocellular carcinoma and has clinicopathologic significance.
Sze KM; Wong KL; Chu GK; Lee JM; Yau TO; Ng IO
Hepatology; 2011 May; 53(5):1558-69. PubMed ID: 21520171
[TBL] [Abstract][Full Text] [Related]
18. MiR-494-3p promotes PI3K/AKT pathway hyperactivation and human hepatocellular carcinoma progression by targeting PTEN.
Lin H; Huang ZP; Liu J; Qiu Y; Tao YP; Wang MC; Yao H; Hou KZ; Gu FM; Xu XF
Sci Rep; 2018 Jul; 8(1):10461. PubMed ID: 29992971
[TBL] [Abstract][Full Text] [Related]
19. miR-9-3p plays a tumour-suppressor role by targeting TAZ (WWTR1) in hepatocellular carcinoma cells.
Higashi T; Hayashi H; Ishimoto T; Takeyama H; Kaida T; Arima K; Taki K; Sakamoto K; Kuroki H; Okabe H; Nitta H; Hashimoto D; Chikamoto A; Beppu T; Baba H
Br J Cancer; 2015 Jul; 113(2):252-8. PubMed ID: 26125451
[TBL] [Abstract][Full Text] [Related]
20. Involvement of PTEN/Akt signaling and oxidative stress on indole-3-carbinol (I3C)-induced hepatocarcinogenesis in rats.
Yamamoto R; Shimamoto K; Ishii Y; Kimura M; Fujii Y; Morita R; Suzuki K; Shibutani M; Mitsumori K
Exp Toxicol Pathol; 2013 Sep; 65(6):845-52. PubMed ID: 23290887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
